Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
Clinical trial NCT01361555 · TERMINATED
Trial details
- NCT number
- NCT01361555
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2013-10-01
- Enrollment
- 789
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.